Funding for this research was provided by:
National Institute for Health Research (PDF-2016-09-009)
Received: 9 January 2020
Accepted: 28 June 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: This study was approved by the West Midlands Edgbaston Research Ethics Committee (Reference 17/WM/ 0010) on 24 February 2017 (prototype development and usability testing) and (Ref: 18/WM/0013) on 23rd February 2018 (ePROM finalisation and pilot trial).
: Not applicable.
: EB and MCh report grants from National Institute for Health Research (NIHR). MCa is a NIHR Senior Investigator and receives funding from the NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre and NIHR ARC West Midlands at the at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UK Research and Innovation), Macmillan Cancer Support, UCB Pharma. MC has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work. DK reports grants from Macmillan Cancer Support, Innovate UK, the NIHR, NIHR Birmingham Biomedical Research Centre, and NIHR SRMRC at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, and personal fees from Merck and GSK outside the submitted work.